{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:35:23Z","timestamp":1788554123079,"version":"build-2803163510"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Kidney transplant patients undergo repeated and frequent venepunctures during allograft management. Microsampling methods that use a fingerprick draw of capillary blood, such as dried blood spots (DBS) and volumetric absorptive microsamplers (VAMS), have the potential to reduce the burden and volume of blood loss with venepuncture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study aimed to examine microsampling approaches for the simultaneous measurement of tacrolimus, mycophenolic acid, mycophenolic acid glucuronide (MPAG), and prednisolone drug concentrations compared with standard venepuncture in adult kidney transplant patients. DBS and VAMS were simultaneously collected with venepuncture samples from 40 adult kidney transplant patients immediately before and 2 hours after immunosuppressant dosing. Method comparison was performed using Passing\u2013Bablok regression, and bias was assessed using Bland\u2013Altman analysis. Drug concentrations measured through microsampling and venepuncture were also compared by estimating the median prediction error (MPE) and median absolute percentage prediction error (MAPE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Passing\u2013Bablok regression showed a systematic difference between tacrolimus DBS and venepuncture [slope of 1.06 (1.01\u20131.13)] and between tacrolimus VAMS and venepuncture [slope of 1.08 (1.03\u20131.13)]. Tacrolimus values were adjusted for this difference, and the corrected values showed no systematic differences. Moreover, no systematic differences were observed when comparing DBS or VAMS with venepuncture for mycophenolic acid and prednisolone. Tacrolimus (corrected), mycophenolic acid, and prednisolone microsampling values met the MPE and MAPE predefined acceptability limits of &lt;15% when compared with the corresponding venepuncture values. DBS and VAMS, collected in a controlled environment, simultaneously measured multiple immunosuppressants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study demonstrates that accurate results of multiple immunosuppressant concentrations can be generated through the microsampling approach, with a preference for VAMS over DBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001024","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:36Z","timestamp":1663027236000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Fingerprick Microsampling Methods Can Replace Venepuncture for Simultaneous Therapeutic Drug Monitoring of Tacrolimus, Mycophenolic Acid, and Prednisolone Concentrations in Adult Kidney Transplant Patients"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-8325","authenticated-orcid":false,"given":"Carla","family":"Scuderi","sequence":"first","affiliation":[{"name":"Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service;"},{"name":"School of Pharmacy, University of Queensland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Parker","sequence":"additional","affiliation":[{"name":"UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Jacks","sequence":"additional","affiliation":[{"name":"Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"John","sequence":"additional","affiliation":[{"name":"Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McWhinney","sequence":"additional","affiliation":[{"name":"Pathology Queensland, Brisbane, Queensland Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Ungerer","sequence":"additional","affiliation":[{"name":"Pathology Queensland, Brisbane, Queensland Health;"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mallett","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland;"},{"name":"Faculty of Medicine, The University of Queensland, Brisbane;"},{"name":"Department of Renal Medicine, Townsville University Hospital;"},{"name":"College of Medicine and Dentistry, James Cook University, Townsville;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Healy","sequence":"additional","affiliation":[{"name":"Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service;"},{"name":"Institute for Molecular Bioscience, The University of Queensland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Roberts","sequence":"additional","affiliation":[{"name":"UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland;"},{"name":"Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane;"},{"name":"Division of Anesthesiology Critical Care Emergency and Pain Medicine,N\u00eemes University Hospital, University of Montpellier, N\u00eemes; and"},{"name":"Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Staatz","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Queensland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Eng J Med."},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the symphony study: observational results 3 Years after transplantation","volume":"9","author":"Ekberg","year":"2009","journal-title":"Am J Transpl."},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guidelines for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl."},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jalm\/jfaa067","article-title":"Point-of-Care therapeutic drug monitoring for precision dosing of immunosuppressive drugs","volume":"5","author":"Taddeo","year":"2020","journal-title":"J Appl Lab Med."},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"e016743","DOI":"10.1371\/journal.pone.0167433","article-title":"Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children","volume":"11","author":"Martial","year":"2016","journal-title":"PLoS One"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2014","journal-title":"Bioanalysis"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"113102","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2016.12.012","article-title":"Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples","volume":"135","author":"Kip","year":"2017","journal-title":"Pharm Biomedanal"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cotox.2017.05.003","article-title":"Alternative sampling strategies for the assessment of biomarkers of exposure","volume":"4","author":"Delahaye","year":"2017","journal-title":"Curr Opin Toxicol."},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot\u2013based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Mon"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R14-20260519","first-page":"140","article-title":"Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation","volume":"21","author":"Cheung","year":"2008","journal-title":"Transpl Int."},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jpba.2006.11.023","article-title":"Therapeutic drug monitoring of tacrolimus with the dried blood spot method","volume":"44","author":"Hoogtanders","year":"2007","journal-title":"J Pharm BiomedAnal"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC-MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"R17-20260519","first-page":"S246","article-title":"Comparison of paired immunosuppressant levels in venous and dried blood spot levels in post-transplant patients","volume":"60","author":"Dickerson","year":"2014","journal-title":"Clin Chem"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/petr.12392","article-title":"Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring","volume":"19","author":"Dickerson","year":"2015","journal-title":"Pediatr Transpl."},{"key":"R19-20260519","first-page":"86","article-title":"Potential for increased compliance with remote dried spot testing of immunosuppressant trough levels?","volume":"19","author":"Sinkey","year":"2015","journal-title":"Pediat Transpl."},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.jchromb.2009.09.037","article-title":"Analysis of mycophenolic acid in dried blood spots using reversed phase high performance liquid chromatography","volume":"877","author":"Wilhelm","year":"2009","journal-title":"J Chromatogr B: Analyt Technol Biomed Life Sci."},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/TP.0000000000001591","article-title":"Clinical validation of simultaneous analysis of tacrolimus, cyclosporine A, and creatinine in dried blood spots in kidney transplant patients","volume":"101","author":"Veenhof","year":"2017","journal-title":"Transplantation"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0004563220948886","article-title":"Assessment of tacrolimus and creatinine concentration collected using Mitra microsampling devices","volume":"57","author":"Marshall","year":"2020","journal-title":"Ann Clin Biochem."},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/FTD.0000000000000873","article-title":"Tacrolimus measured in capillary volumetric microsamples in pediatric patients-a cross-validation study","volume":"43","author":"Kindem","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R24-20260519","first-page":"S75","article-title":"Simultaneous LC-MS\/MS quantification of creatinine, iohexol and five immunosuppressants in volumetric microsamples for remote renal transplant recipient monitoring","volume":"109","author":"Zwart","year":"2021","journal-title":"ClinPharm Therap"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"113422","DOI":"10.1016\/j.jpba.2020.113422","article-title":"Volumetric Absorptive Microsampling (VAMS) for assaying immunosuppressants from venous whole blood by LC\u2013MS\/MS using a novel atmospheric pressure ionization probe (UniSpray\u2122)","volume":"189","author":"Paniagua-Gonz\u00e1lez","year":"2020","journal-title":"Pharm Biomed Anal."},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.clinbiochem.2013.10.011","article-title":"Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients","volume":"46","author":"Arpini","year":"2013","journal-title":"Clin Biochem."},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"e12983","DOI":"10.1111\/petr.12983","article-title":"Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation","volume":"21","author":"Al-Uzri","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R28-20260519","first-page":"20191260","article-title":"Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring","author":"Veenhof","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03601.x","article-title":"Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team","volume":"11","author":"Alloway","year":"2011","journal-title":"Am J Transpl."},{"key":"R30-20260519","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I","volume":"21","author":"Passing","year":"1983","journal-title":"Jclin Chem Biochem."},{"key":"R31-20260519","first-page":"503","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinetbiopharm"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"114443","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonz\u00e1lez","year":"2022","journal-title":"Pharma Biomed Anal"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem."},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FTD.0000000000000697","article-title":"Tacrolimus area under the concentration versus time curve monitoring, using home-based volumetric absorptive capillary microsampling","volume":"42","author":"Gustavsen","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FTD.0000000000000833","article-title":"Quantitation of tacrolimus in human whole blood samples using the MITRA microsampling device","volume":"43","author":"Undre","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/FTD.0000000000000847","article-title":"Validation of a capillary dry blood sample MITRA-based assay for the quantitative determination of systemic tacrolimus concentrations in transplant recipients","volume":"43","author":"Undre","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchromb.2011.05.016","article-title":"Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry","volume":"883-884","author":"Hinchliffe","year":"2012","journal-title":"J Chromatog B Analyt Technol Biomed Life Sci."},{"key":"R39-20260519","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/138920009787522205","article-title":"Therapeutic monitoring of mycophenolate in transplantation: is it justified?","volume":"10","author":"Barraclough","year":"2009","journal-title":"Curr Drug Metab."},{"key":"R40-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00467-016-3352-2","article-title":"The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy","volume":"32","author":"Filler","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"R41-20260519","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1440-1797.2011.01560.x","article-title":"A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients","volume":"17","author":"Barraclough","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"R42-20260519","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bcp.13850","article-title":"Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus","volume":"85","author":"Zhang","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"R43-20260519","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch Toxicol."},{"key":"R44-20260519","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4155\/bio.10.99","article-title":"Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots","volume":"2","author":"Heinig","year":"2010","journal-title":"Bioanalysis"},{"key":"R45-20260519","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/FTD.0b013e318187bb2f","article-title":"Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation","volume":"30","author":"Bergrem","year":"2008","journal-title":"Ther Drug Monit."},{"key":"R46-20260519","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation","volume":"51","author":"Bergmann","year":"2012","journal-title":"ClinPharmacokinet"},{"key":"R47-20260519","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/FTD.0000000000000835","article-title":"Prednisolone and prednisone pharmacokinetics in adult renal transplant recipients","volume":"43","author":"Skauby","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R48-20260519","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40261-015-0334-2","article-title":"Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients","volume":"35","author":"Bergmann","year":"2015","journal-title":"Clin Drug Investig."},{"key":"R49-20260519","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trac.2015.11.016","article-title":"Recent advances in therapeutic drug monitoring of immunosuppressive drugs","volume":"79","author":"Freudenberger","year":"2016","journal-title":"Trend Anal Chem."},{"key":"R50-20260519","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/bio-2016-0296","article-title":"Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS\/MS systems","volume":"9","author":"Koster","year":"2017","journal-title":"Bioanalysis"},{"key":"R51-20260519","doi-asserted-by":"crossref","first-page":"113491","DOI":"10.1016\/j.jpba.2020.113491","article-title":"Hematocrit prediction in volumetric absorptive microsamples","volume":"190","author":"Capiau","year":"2020","journal-title":"J Pharm Biomed Anal."},{"key":"R52-20260519","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4155\/bio-2020-0057","article-title":"Kidney transplant recipient's perceptions of blood testing through microsampling and venepuncture","volume":"12","author":"Scuderi","year":"2020","journal-title":"Bioanalysis"},{"key":"R53-20260519","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ki.2013.484","article-title":"Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation","volume":"85","author":"van Gelder","year":"2014","journal-title":"Kidney Int"},{"key":"R54-20260519","doi-asserted-by":"crossref","first-page":"461731","DOI":"10.1016\/j.chroma.2020.461731","article-title":"A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring","volume":"1635","author":"Tey","year":"2021","journal-title":"J Chromatogr A."},{"key":"R55-20260519","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/FTD.0000000000000655","article-title":"Tacrolimus can Be reliably measured with volumetric absorptive capillary microsampling throughout the dose interval in renal transplant recipients","volume":"41","author":"Vethe","year":"2019","journal-title":"Ther Drug Monit."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:00:25Z","timestamp":1779224425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001024","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}